Ruiwu Liu Selected Research

Cell Surface Receptors

1/2009	Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.
11/2007	Highly potent, water soluble benzimidazole antagonist for activated alpha 4 beta 1 integrin.
9/2007	From combinatorial chemistry to cancer-targeting peptides.
7/2006	Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.
6/2006	Peptide ligands targeting integrin alpha3beta1 in non-small cell lung cancer.
5/2005	Identification of novel targeting peptides for human ovarian cancer cells using "one-bead one-compound" combinatorial libraries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruiwu Liu Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 02/2004
9	Lymphoma (Lymphomas) 01/2015 - 07/2006
6	Neoplasm Metastasis (Metastasis) 11/2019 - 10/2010
5	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 09/2007
5	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2007
4	Inflammation (Inflammations) 11/2020 - 01/2006
4	Glioblastoma (Glioblastoma Multiforme) 12/2016 - 05/2005
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2012 - 09/2007
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 06/2006
3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 05/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 03/2016
3	Leukemia 01/2014 - 01/2006
3	Alzheimer Disease (Alzheimer's Disease) 02/2011 - 01/2008
3	Lung Neoplasms (Lung Cancer) 09/2007 - 10/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019 - 12/2012
2	Adenocarcinoma of Lung 10/2019 - 06/2006
2	Kidney Neoplasms (Kidney Cancer) 06/2013 - 12/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Carcinoma (Carcinomatosis) 12/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Fetal Diseases (Embryopathy) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Neurofibrosarcoma (MPNST) 11/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2019
1	Mouth Neoplasms (Oral Cancer) 09/2019
1	Shellfish Hypersensitivity 03/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Genomic Instability 07/2014
1	Cardiotoxicity 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014

Drug/Important Bio-Agent (IBA)

20	LigandsIBA 01/2020 - 10/2004
14	Peptides (Polypeptides)IBA 07/2021 - 10/2004
11	IntegrinsIBA 10/2019 - 05/2005
7	Pharmaceutical PreparationsIBA 07/2021 - 02/2004
7	PeptidomimeticsIBA 01/2015 - 01/2006
6	Integrin alpha4beta1 (VLA-4)IBA 05/2012 - 10/2004
6	Cell Surface ReceptorsIBA 01/2009 - 05/2005
5	Cyclic PeptidesIBA 12/2020 - 01/2009
5	Peptide LibraryIBA 09/2019 - 09/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 12/2008
2	HydrogelsIBA 01/2020 - 01/2020
2	Galectin 1 (LGALS1)IBA 11/2019 - 01/2018
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 11/2019 - 01/2018
2	StreptavidinIBA 10/2019 - 10/2010
2	CY5.5 cyanine dyeIBA 10/2019 - 10/2010
2	MicroRNAs (MicroRNA)IBA 05/2017 - 11/2012
2	LipidsIBA 05/2017 - 03/2016
2	Amino Acids FDA Link 03/2017 - 01/2007
2	C-Reactive ProteinIBA 01/2017 - 06/2013
2	AlbuminsIBA 01/2017 - 01/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2016 - 01/2007
2	Caspase 3 (Caspase-3)IBA 01/2015 - 01/2014
2	Amyloid (Amyloid Fibrils)IBA 02/2011 - 10/2010
2	Amyloid beta-PeptidesIBA 10/2010 - 01/2008
2	Urea (Carbamide)FDA LinkGeneric 01/2009 - 11/2007
2	Integrin alpha3IBA 01/2009 - 05/2005
1	CytokinesIBA 01/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	CholesterolIBA 01/2022
1	VTP-43742IBA 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020
1	CollagenIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	erucylphosphocholineIBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2019
1	CXC ChemokinesIBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 11/2019
1	Biotin (Vitamin H)FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	Docetaxel (Taxotere)FDA Link 01/2018
1	AndrogensIBA 01/2018
1	SolutionsIBA 05/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2017
1	TropomyosinIBA 03/2017
1	Immunoglobulin E (IgE)IBA 03/2017
1	GlobulinsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2016
1	3,3'-Diaminobenzidine (3,3 Diaminobenzidine)IBA 01/2015
1	Horseradish PeroxidaseIBA 01/2015
1	Histone DemethylasesIBA 07/2014
1	Lysine (L-Lysine)FDA Link 07/2014
1	Androgen Receptors (Androgen Receptor)IBA 07/2014
1	MicellesIBA 01/2014
1	MB Form Creatine KinaseIBA 01/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2014

Therapy/Procedure

12	Therapeutics 12/2020 - 07/2006
3	Drug Therapy (Chemotherapy) 06/2013 - 12/2008
1	Injections 01/2020
1	Transplantation 01/2020
1	Castration 01/2018
1	Lasers (Laser) 05/2017
1	Nephrectomy 01/2017